Other languages Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-06-10 am EDT			5-day change	1st Jan Change
5,788 ^JPY	-0.70%		+3.76%	+49.48%

Jun. 04	Daiichi Sankyo Buys Back Shares Worth Over 29 Billion Yen in May	MT
Jun. 04	Transcript : Daiichi Sankyo Company, Limited - Special Call

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Daiichi Sankyo Buys Back Shares Worth Over 29 Billion Yen in May	Jun. 03
AstraZeneca Says Potential Breast Cancer Treatment Reduces Risk of Disease Progression by up to 38%	Jun. 03
AstraZeneca Reports Positive Results for Metastatic Breast Cancer Drug	Jun. 03
Les valeurs à suivre à Paris et en Europe (actualisé)	Jun. 03
Astra's Enhertu breast cancer trial shows 'unprecedented' results	Jun. 02
Astra's Enhertu delays breast cancer in patients with low HER2 levels	Jun. 02
Astrazeneca Safety Profile Of Enhertu Was Consistent With Previous Breast Cancer Clinical Trials With No New Safety Concerns Identified	Jun. 02
Daiichi Sankyo and AstraZeneca PLC Provides Positive Results from the DESTINY-Breast06 Phase 3 Trial	Jun. 02
AstraZeneca and Daiichi Sankyo Announce Positive Results from the DESTINY-Breast06 Phase III Trial Showed That ENHERTU Metastatic Breast Cancer and the Overall Trial Population	Jun. 02
RevolKa Signs Master Service Agreement with Daiichi Sankyo	May. 27
AstraZeneca, Daiichi Sankyo’s Lung Cancer Drug Shows Mixed Results in Late-stage Trial	May. 27
AstraZeneca's Lung Cancer Drug Shows Clinically Meaningful Improvement in Overall Survival	May. 27
Astra, Daiichi hail positive survival data for Dato-DXd	May. 27
Daiichi Sankyo and AstraZeneca PLC Provides an update on TROPION-Lung01 Phase 3 Trial	May. 27
AstraZeneca to build $1.5-bln cancer drug plant in Singapore	May. 20
Merck : va présenter de nouvelles données en oncologie	May. 15
Japan's Nikkei closes at 3-week high on US rate-cut outlook, tech boost	May. 07
Japan's Nikkei climbs on Fed rate-cut outlook, tech boost	May. 06
Remsons, Daiichi Infotainments Form Joint Venture	Apr. 30
AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement	Apr. 29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Other languages

Filters